Skip to main content

Fred Kao Named Vice President of Global Sales for Amlan International

CHICAGO, Sept. 10, 2020 (GLOBE NEWSWIRE) — Amlan International, a global leader in developing innovative solutions that improve livestock intestinal health and productivity, is proud to name Fred H. Kao for the new role of Vice President of Global Sales.
The creation of this position further supports the company’s investment in the gut health product line for the global market. Driven by increasing consumer demand for protein produced without antibiotics, Amlan International is excited to move confidently forward to provide animal health solutions for their customers.Kao brings to the company 20 years of expertise in building strong relationships with key integrators in the animal protein business. Kao has worked in Europe, Middle East, African and Asia Pacific regions since 2004. He most recently managed the Asia Pacific business unit for Cobb-Vantress Inc.In the span of just two years, Kao oversaw changes in the Cobb-Vantress business operations in China that led to significant profitability for the company. He structured operations in the Philippines for long term growth and oversaw the development of Cobb’s New Zealand project. “Fred H. Kao’s ability to create relationships with the sales team as well as key integrators will position Amlan International to achieve new heights in emerging markets,” says Flemming L. Mahs, President of Amlan International. “Fred is a generator of new ideas and an innovative new business developer. Amlan’s growing global sales team is essential to match the demand for our products worldwide. With his leadership, Amlan will be well-positioned to meet the demands of livestock producers for natural alternatives to antibiotic growth promoters and intestinal health.”Prior to his work with Cobb-Vantress, Kao worked for more than 16 years for Aviagen Inc. where he managed a team of eight commercial and technical managers and more than doubled the responsible brand’s worldwide Parent Stock shares.Kao is a 2000 graduate of the University of Arkansas. He is fluent in Mandarin and Cantonese and competent in two other languages (Japanese and Spanish), which is an important asset to connecting with a diverse and growing customer base.Amlan InternationalOil-Dri Corporation of America (NYSE: ODC), a Delaware corporation doing business as “Amlan International,” is a global leader in proven solutions that improve the intestinal health and productivity of livestock. Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Illinois.  Flemming L. Mahs is President of Amlan International, a subsidiary of Oil-Dri Corporation of America.Amlan International sells animal health products outside of the United States. Product associated claims do not constitute medical claims and may differ based on government requirements. Product availability may vary by country.Reagan Culbertson
Media Contact
press@amlan.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e1bd733f-368d-4b9c-a60c-229255e9336a

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.